Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Diverse targets for intervention during inflammatory and neurodegenerative phases of multiple sclerosis Zamvil SS; Steinman LNeuron 2003[Jun]; 38 (5): 685-8Multiple sclerosis (MS) is an autoimmune central nervous system (CNS) demyelinating disease that causes relapsing and chronic neurologic impairment. Recent observations have altered certain traditional concepts regarding MS pathogenesis. A greater diversity of cell types and molecules involved in MS is now evident. While remyelination can occur during the early inflammatory phase when damage may be reversible, it is impaired in the later stages, which involve axonal death. These observations have important therapeutic implications.|Animals[MESH]|Autoantibodies/immunology[MESH]|Axons/*immunology/metabolism/pathology[MESH]|CD4-Positive T-Lymphocytes/immunology[MESH]|Cell Death/*immunology[MESH]|Encephalitis/drug therapy/*immunology/physiopathology[MESH]|Humans[MESH]|Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology/therapeutic use[MESH]|Multiple Sclerosis/drug therapy/*immunology/physiopathology[MESH]|Myelin Sheath/*immunology/metabolism/pathology[MESH]|Nerve Degeneration/drug therapy/*immunology/physiopathology[MESH] |